Sponsor Dossier
Pfizer
Sponsor Dossier for Pfizer. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ABRILADA
- Brand: ABRYSVO
- Brand: ADRIAMYCIN
- Brand: Alcoholic
- Brand: ALDACTONE
- Brand: ANZATAX
- Brand: ARICEPT
- Brand: AROMASIN
- Device (sponsor): Hypodermic needle, single-use, sterile
- Device (sponsor): Skin-cleaning wipe, sterile
- Device (sponsor): Skin-cleaning wipe, sterile
- Device (sponsor): Electronic insulin pen
- Device (sponsor): Medicine administration kit, percutaneous, medicated, single-use
- Device (sponsor): Medicine administration kit, percutaneous, medicated, single-use
- Device (sponsor): Holder, <specify>
- Device (sponsor): Medicine administration kit, percutaneous, medicated, single-use
- Device (sponsor): Self-injection aid
- Device (sponsor): Medicine administration kit, percutaneous, medicated, single-use
- Device (sponsor): Medicine administration kit, percutaneous, medicated, single-use
- Device (sponsor): Medicine administration kit, percutaneous, medicated, single-use
- Device (sponsor): Medicine administration kit, percutaneous, medicated, single-use
- Device (sponsor): Medicine administration kit, percutaneous, medicated, single-use
- Device (sponsor): Self-injection aid
- Device (sponsor): Medicine administration kit, percutaneous, medicated, single-use
About
Pfizer is an Australian Private Company with ABN 50008422348, registered in NSW. The company is active and registered for GST from 1 July 2000.
Portfolio
Pfizer's ARTG portfolio comprises 126 brands, of which 112 are indexable. The company has 106 brands with Product Information on file, 45 brands with at least one PBS-listed item, 47 brands with PBAC outcomes on record, and 23 brands with AusPARs on record.
Therapeutic focus
Pfizer's portfolio is distributed across the following therapeutic areas: — Oncology: 35 brands — Infectious Disease: 23 brands — Immunology: 11 brands — Neurology: 9 brands — Cardiology: 9 brands — Reproductive Health: 7 brands — Haematology: 6 brands — Dermatology: 6 brands — Women's Health: 5 brands — Endocrinology: 3 brands — Pain & Anaesthesia: 3 brands — Respiratory: 2 brands — Gastroenterology: 2 brands — Pain Management: 2 brands — Complementary Medicine: 1 brand — Urology: 1 brand — Psychiatry: 1 brand
PBS footprint
Pfizer has 45 brands with at least one PBS-listed item, with the portfolio most recently touching the PBS schedule on 1 May 2026.
Regulatory activity
Pfizer's most recent PBAC outcome was dated 1 December 2025, with 47 brands holding PBAC outcomes on record. The company's most recent AusPAR was dated 29 January 2025, with 23 brands holding AusPARs on record.